Heru, which is building a tool that uses AI and commercial AR/VR headsets to diagnose eye conditions and vision loss, raises $30M Series A led by D1 Capital (Conor Hale/FierceBiotech)
Heru, which is building a tool that uses AI and commercial AR/VR headsets to diagnose eye conditions and vision loss, raises $30M Series A led by D1 Capital (Conor Hale/FierceBiotech) https://bit.ly/3oK9y3k
Conor Hale / FierceBiotech:
Heru, which is building a tool that uses AI and commercial AR/VR headsets to diagnose eye conditions and vision loss, raises $30M Series A led by D1 Capital — The classic eye chart wall poster is getting an upgrade, with newcomer Heru looking to bring vision tests into virtual reality.
0 Response to "Heru, which is building a tool that uses AI and commercial AR/VR headsets to diagnose eye conditions and vision loss, raises $30M Series A led by D1 Capital (Conor Hale/FierceBiotech)"
Post a Comment
THANK YOU